Abstract
The technique of extended mantle radiotherapy for Hodgkin's disease and other malignant lymphomas is described. Morbidity was entirely acceptable in younger patients despite the increased integral dose. Contraindications include severe reactions, recent chemotherapy, uncontrolled medical problems, and advanced age. The possible role of splenectomy in the success of extended mantle therapy is discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
